Company: TVRD
Filing Date: 2025-10-20
Form Type: S-1/A
Source: 0001104659-25-100896
Chunk: 334

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-10-20
Form: S-1/A
Chunk 334
---
 dated as of March 2018. The following tables summarize the Company’s redeemable convertible preferred stock as of December 31, 2024 and 2023 (in thousands except share and per share amounts):

| ​                        | ​ | ​ | Par Value |   |       |   | ​ | ​ | PreferredStockAuthorized |   |            |   | ​ | ​ | PreferredStockIssued andOutstanding |   |            |   | ​ | ​ | CarryingValue |   |        |   | ​ | ​ | LiquidationPreference |   |        |   | ​ | ​ | CommonStockIssuableUponConversion |   |            |   | ​ |
|:-------------------------|:--|:--|:----------|:--|------:|:--|:--|:--|:-------------------------|:--|-----------:|:--|:--|:--|:------------------------------------|:--|-----------:|:--|:--|:--|:--------------|:--|-------:|:--|:--|:--|:----------------------|:--|-------:|:--|:--|:--|:----------------------------------|:--|-----------:|:--|:--|
| Series A preferred stock | ​ | ​ | ​         | $ | 0.001 | ​ | ​ | ​ | ​                        | ​ |  9,499,999 | ​ | ​ | ​ | ​                                   | ​ |  9,499,999 | ​ | ​ | ​ | ​             | $ |  9,327 | ​ | ​ | ​ | ​                     | $ |  9,500 | ​ | ​ | ​ | ​                                 | ​ |  9,499,999 | ​ | ​ |
| Series B preferred stock | ​ | ​ | ​         | ​ | 0.001 | ​ | ​ | ​ | ​                        | ​ | 20,223,541 | ​ | ​ | ​ | ​                                   | ​ | 20,055,539 | ​ | ​ | ​ | ​             | ​ | 76,176 | ​ | ​ | ​ | ​                     | ​ | 76,402 | ​ | ​ | ​ | ​                                 | ​ | 20,055,539 | ​ | ​ |
| ​                        | ​ | ​ | ​         | ​ |     ​ | ​ | ​ | ​ | ​                        | ​ |